Bariatric Surgery for Severe Obesity

Introduction to Bariatric Surgery

The American College of Physicians guidelines recommend surgery for patients with BMI ≥40 kg/m² who have failed adequate diet and exercise programs 1, 2
Bariatric surgery achieves loss of approximately two-thirds of excess weight within 2 years, with maintenance of approximately one-half of excess weight loss for more than 10 years 3

Orlistat achieves only 2.89 kg weight loss at 12 months, which is clinically insignificant for someone with BMI 42 1, 2
Other available medications achieve only 2.8-4.45 kg weight loss at 6-12 months 1, 2
There is no evidence of mortality benefits from the modest weight loss achieved with medications 1, 2

Long-term studies demonstrate improvement in all-cause survival, with decreased deaths from diabetes and coronary artery disease compared to non-surgical cohorts 4
Surgery leads to substantial improvements in hypertension, dyslipidemia, obstructive sleep apnea, NAFLD, GERD, and other obesity-related conditions 3, 4

Overall perioperative mortality ranges from 0.1% to 0.3% 4
Reported mortality rates range from 0.3% to 1.9%, with better outcomes at high-volume centers 1, 2
Patients should be referred to high-volume centers with surgeons experienced in bariatric surgery to optimize outcomes 1, 2

Counsel the patient that bariatric surgery is proven to be safe and the most efficacious and durable treatment for severe obesity 4
Refer to a high-volume bariatric surgery center with experienced surgeons 1, 2
Ensure the patient understands that long-term success requires continued participation in a comprehensive lifestyle program post-operatively 4

The National Heart Lung Blood Institute guidelines recommend bariatric surgery for patients with BMI ≥40 kg/m² regardless of comorbidities 5, 6.
Patients with BMI 35-39.9 kg/m² may be considered for bariatric surgery if they have severe comorbidities, including established coronary heart disease, other atherosclerotic diseases, type 2 diabetes, or sleep apnea 5, 6.
The American College of Cardiology and other guideline societies support the use of bariatric surgery for patients with BMI ≥35 kg/m² and severe comorbidities, or BMI ≥40 kg/m² with or without comorbidities 5, 6, 7, 8.

Bariatric surgery can provide substantial benefits for patients with multiple comorbidities, including mortality reduction, with large observational studies demonstrating decreased all-cause mortality, deaths from diabetes, and deaths from coronary artery disease 5, 6.
Most patients experience complete remission or significant improvement of type 2 diabetes after bariatric surgery, often within days of surgery 9.

Patients should have attempted conventional weight loss methods, such as diet, exercise, and behavioral therapy, before surgery, although surgical intervention should not be unduly delayed in patients with treatment-resistant hypertension and multiple severe comorbidities 7, 10.